We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Infection by Meningitis Bacteria Depends on Dimerization State of Certain Host Cell Proteins

By LabMedica International staff writers
Posted on 15 Oct 2014
A team of molecular microbiologists has untangled the complex three-way interaction between the non-integrin laminin receptor (LAMR1), galectin-3 (Gal-2), and the pathogenic bacterium Neisseria meningitidis.

Neisseria meningitidis, the causative agent of meningococcal meningitis, is found in the nasopharynx of humans but not in other animals. More...
How this organism interacts and invades tissues has been of great interest to medical microbiologists. In the current study, investigators at The University of Nottingham (United Kingdom) examined the roles of two host cell-surface proteins, Galectin-3 and laminin receptor 1, in the process of infection.

Galectin-3 (Gal-3) is one of the 14 recognized mammalian lectins. This protein weighs approximately 30 kDa and, like all galectins, contains a carbohydrate-recognition-binding domain of about 130 amino acids that enables the specific binding of beta-galactosides. Gal-3 is expressed in cells in the nucleus, cytoplasm, mitochondrion, cell surface, and extracellular space. This protein has been shown to be involved in cell adhesion, cell activation and chemoattraction, cell growth and differentiation, cell cycle, and apoptosis. Gal-3 recognizes the Thomsen-Friedenreich disaccharide (TFD, galactose-N-acetylgalactosamine) that is present on the surface of most cancer cells and is involved in promoting angiogenesis, tumor-endothelial cell adhesion, and metastasis of prostate cancer cells, as well as evading immune surveillance through killing of activated T-cells.

Laminins, a family of extracellular matrix glycoproteins, are the major noncollagenous constituent of basement membranes. They have been implicated in a wide variety of biological processes including cell adhesion, differentiation, migration, signaling, and metastasis. Many of the effects of laminin are mediated through interactions with cell surface receptors. These receptors include members of the integrin family, as well as non-integrin laminin-binding proteins. The ribosomal protein SA gene encodes a high-affinity, non-integrin family, laminin receptor 1 (LAMR1). This receptor has been variously called 67-kDa laminin receptor, 37-kDa laminin receptor precursor (37LRP) and p40 ribosome-associated protein. The amino acid sequence of laminin receptor 1 is highly conserved through evolution, suggesting a key biological function.

In their paper, which was published in the October 1, 2014, online edition of the journal Open Biology, the investigators described using advanced bimolecular fluorescence and confocal imaging techniques to show that Gal-3 and LAMR1 formed homo- and heterodimers, and that each isotype formed a distinct cell surface population. The 37-kDa form of LAMR1 (37LRP) was the precursor of the previously described 67-kDa laminin receptor (67LR), whereas the heterodimer represented an entity that was distinct from this molecule. Site-directed mutagenesis confirmed that the single cysteine (C173) of Gal-3 or lysine (K166) of LAMR1 were critical for heterodimerization. Recombinant Gal-3, expressed in normally Gal-3-deficient N2a cells, dimerized with endogenous LAMR1 and led to a significantly increased number of internalized bacteria, confirming the role of Gal-3 in bacterial invasion.

Contributing author Dr. Karl Wooldridge, associate professor of microbiology at The University of Nottingham, said, “We have shown evidence for the self and mutual association of these two important proteins and their distinctive surface distribution on the human cell. We have also demonstrated that they are targeted by the serious human pathogen Neisseria meningitidis. This is significant because these proteins could potentially be used to develop new vaccines and treatments which could sabotage the colonization of these dangerous bacteria, and also which could protect the blood-brain barrier which is disrupted in cases of bacterial meningitis.”

Related Links:

The University of Nottingham



Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
CBM Analyzer
Complete Blood Morphology (CBM) Analyzer
Gold Member
Radial Immunodiffusion Assay
Radial Immunodifusion - C3 ID
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Industry

view channel
Image: The LIAISON NES molecular point-of-care platform (Photo courtesy of Diasorin)

Diasorin and Fisher Scientific Enter into US Distribution Agreement for Molecular POC Platform

Diasorin (Saluggia, Italy) has entered into an exclusive distribution agreement with Fisher Scientific, part of Thermo Fisher Scientific (Waltham, MA, USA), for the LIAISON NES molecular point-of-care... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.